10 results on this page
Kuaishou is spinning out its Kling AI video-generation model into a separately financed company, attracting investment from Tencent, Alibaba Cloud, Baidu, and other institutions at an implied valuation of $18 billion. Kling has surpassed 100 million global users and nearly 50,000 enterprise customers, but continues to generate substantial losses because of compute costs.
Eagle Point Credit Management is providing roughly $1.3 billion in private credit for a large Texas data center tied to Anthropic. The financing gives the investment firm a significant role in a major AI infrastructure project.
Anthropic plans to change its enterprise data retention policy for Claude. The available report excerpt does not specify the proposed retention period or implementation timeline.
AntLing has released six official Ling-3.0 base checkpoints spanning two model sizes and three training stages. The MIT-licensed, ungated repositories are intended for continued pretraining, fine-tuning, and research rather than direct chat use.
AWS outlines enterprise patterns for operating many agentic AI systems across diverse frameworks, models, and providers. The guidance focuses on preserving flexibility and enabling multi-agent systems to scale together without vendor lock-in.
Generative recommenders are shifting recommendation objectives from embedding similarity toward predicting a user's next action or item. The approach uses user-history sequences and large catalogs to rethink how recommendation systems are trained and served at scale.
AWS demonstrates how Amazon Bedrock can add context-aware security monitoring to healthcare FHIR APIs. The approach detects anomalous access patterns, classifies data sensitivity, and generates natural-language compliance reports without adding latency to clinical workflows.
AMACO’s $1.5 billion HERCULES project in Kenya combines electricity generation, cooling, and AI data-centre infrastructure. Its initial design uses liquefied natural gas to reduce reliance on the national grid, with future support for renewable energy and hydrogen.
Moderna and Merck reported positive Phase 3 results for personalized mRNA cancer vaccine mRNA-4157 combined with pembrolizumab in high-risk melanoma after surgery. The treatment significantly improved recurrence-free and distant metastasis-free survival versus pembrolizumab alone, though detailed data and overall survival results are still pending.
SMIC reported its first $3 billion quarter, with revenue rising 36.1% year over year and net profit nearly tripling to $479.2 million. The Chinese foundry is also raising wafer prices as US sanctions strengthen demand from China’s captive AI market.